Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-25 @ 9:51 PM
Study NCT ID:
NCT02951351
Status:
COMPLETED
Last Update Posted:
2023-04-12
First Post:
2016-10-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
Detailed Description:
To ensure the extra drop does not interfere with antisepsis, conjunctival cultures will be obtained from patients undergoing intravitreal injection before and after the application of the extra eye drop. Patients will be randomized to undergo additional topical analgesia during intravitreal injection vs. the standard amount of topical analgesia. Cultures of the eyelid/conjunctiva will be taken to ensure that the additional topical analgesia does not interfere with antisepsis.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: